Thomas Inglesby, MD, is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats.
Public Health Preparedness; Biosecurity; Health Security; Emerging Infectious Diseases; Resilience; Biological Threats; Dual Use; Science Policy; Public Policy; Laboratory Safety; Healthcare Preparedness; Preparedness; Global Health Security
Experiences & Accomplishments
Dr. Inglesby is a Professor with joint appointments at the Johns Hopkins Bloomberg School of Public Health and in the Johns Hopkins School of Medicine. Until January 16, 2017, he was Professor in the University of Pittsburgh’s School of Medicine, Department of Medicine, in the Division of Infectious Diseases with a secondary appointment as Professor at the University of Pittsburgh Graduate School of Public Health. He joined the faculty of the University of Pittsburgh Schools of Medicine and Public Health in 2003 as Associate Professor. Prior to that, he was Assistant Professor in the Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Diseases.
Dr. Inglesby is also the Director of the Johns Hopkins Center for Health Security, serving in that role since 2016. The Center was originally founded by DA Henderson in 1998 at the Johns Hopkins School of Public Health. The mission of the Center is to protect people from epidemics and disasters through independent research, policy analysis, and program assessment. He and his Center colleagues study the organizations, policies, systems and tools intended to prevent and respond to epidemics and other major public health crises. He directs the group of 20 full-time and 8 part-time scholars, research staff, and editorial and administrative staff at the Center. Dr. Inglesby received his BA from Georgetown University and his MD from Columbia University College of Physicians and Surgeons. He completed his Internal Medicine residency and Infectious Diseases Fellowship at Johns Hopkins University Hospital. He was Assistant Chief of Service in the Johns Hopkins Department of Medicine from 1996-1997.
Selected publications intended to represent different areas of my research and policy interests.
Schoch-Spana M, Cicero A, Adalja A, Gronvall G, Kirk Sell T, Meyer D, Nuzzo J, Ravi S, Shearer M, Toner E, Watson C, Watson M, Inglesby TV. Global Catastrophic Biological Risks: Toward a Working Definition. Health Security. 2017 July, in press.
Adalja A, Toner E, Inglesby TV. Clinical Management of Potential Bioterrorism-Related Conditions. New England Journal of Medicine 2015 Mar 5; 372:954-962.
Lipsitch, M, Inglesby TV. Moratorium on Research Intended to Create Novel Potential Pandemic Pathogens. Mbio 2014 Dec 12;5(6). pii: e02366-14. doi: 10.1128/mBio.02366-14.
Nuzzo J, Cicero A, Waldhorn R, Inglesby TV. Travel bans will increase the damage wrought by Ebola. Biosecur Bioterror 2014;12(6):306-309. doi: 10.1089/bsp.2014.1030.
Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MA, Eitzen E, et.al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287(17):2236-2252.